George Clinical is pleased to confirm the appointment of Mary Gunn as its new Chief Executive Officer. As a global executive, Mary brings to the role extensive experience in high-growth life sciences, financial services, and the education sectors. Mary will also be a director on the Board.

Mary Gunn succeeds James Cheong who has served as CEO for five and a half years

The Board of George Clinical extends its gratitude to James for his dedication and significant contributions to the company over this time.

For further information about Mary Gunn, click here.